Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News

ETF Overview

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.

Key Stats

• Today's Range: $5.59 to $5.84
• 50-Day Range: $5.60 to $7.73
• 52-Week Range: $4.78 to $16.05
• Volume: 14.66 million shs
• Average Volume: 14.82 million shs
• Market Capitalization: $89.71 million
• Assets Under Management: $63.51 million
• Dividend Yield: 4.82%
• Net Expense Ratio: 1.07%
• Aggregate Rating: N/A

LABD ETF - Frequently Asked Questions

How have LABD shares performed this year?

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 at the beginning of 2025. Since then, LABD stock has decreased by 22.8% and is now trading at $5.60.

When did Direxion Daily S&P Biotech Bear 3x Shares' stock split?

Direxion Daily S&P Biotech Bear 3x Shares shares reverse split on the morning of Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders?

Top institutional investors of Direxion Daily S&P Biotech Bear 3x Shares include Jump Financial LLC (1.09%), Group One Trading LLC (0.28%) and Envestnet Asset Management Inc. (0.09%).

How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares?

Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC).

Fund Details

• Issuer: Direxion
• Fund Name: Direxion Daily S&P Biotech Bear 3x Shares
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:LABD
• Inception Date: 5/28/2015
• Fund Manager: Paul Brigandi, Tony Ng
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: S&P Biotechnology Select Industry Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 21

Fund Statistics

• Assets Under Management: $63.51 million
• Average Daily Volume: $17.81 million
• Discount/Premium: 0.00%
• Leveraged: -3.00

Administrator, Advisor and Custodian

• Administrator: U.S. Bancorp Fund Services, LLC
• Advisor: Rafferty Asset Management, LLC
• Custodian: The Bank of New York Mellon Corporation
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: Optionable
• Options Volume: 314
• Put Options: 150
• Call Options: 164
• Short Interest: 1,050,000 shs

Miscellaneous

• Outstanding Shares: 16,020,000
• Beta: -2.40
• Creation Unit: 50,000
• Creation Fee: $250.00